NCT00417196View on ClinicalTrials.gov

Safety, Pharmacodynamic and Pharmacokinetic Effects of QAX576 in Healthy Volunteers.

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

December 31, 2006

Study Completion Date

August 31, 2007

Conditions
Healthy
Interventions
DRUG

QAX576

Trial Locations (1)

07936-1080

Novartis Investigative Site, East Hanover

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY

NCT00417196 - Safety, Pharmacodynamic and Pharmacokinetic Effects of QAX576 in Healthy Volunteers. | Biotech Hunter | Biotech Hunter